Screener
Bio-Rad Laboratories BIO FX & Other Adjustments
FX & Other Adjustments at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.
The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000012208-26-000035
| Balances as of December 31, 2025 | Life Science | Clinical Diagnostics | Total |
|---|---|---|---|
| Goodwill | $493.2 | $421.8 | $915.0 |
| Accumulated impairment losses | (41.8) | (293.4) | (335.2) |
| Goodwill, net | 451.4 | 128.4 | 579.8 |
| Foreign currency adjustments | (2.7) | — | (2.7) |
| Period change, net | (2.7) | — | (2.7) |
| Balances as of March 31, 2026 | |||
| Goodwill | 490.5 | 421.8 | 912.3 |
| Accumulated impairment losses | (41.8) | (293.4) | (335.2) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bio-Rad Laboratories's FX & other adjustments?
- Bio-Rad Laboratories (BIO) reported FX & other adjustments of -$2.7M in Q1 2026.
- How has Bio-Rad Laboratories's FX & other adjustments changed year-over-year?
- Bio-Rad Laboratories's FX & other adjustments decreased by 165.9% year-over-year, from $4.1M to -$2.7M.
Ask your AI about Bio-Rad Laboratories's fx & other adjustments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude